Advertisement
ANAB vs QTTB
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANAB is a StrongBuy and QTTB is a StrongBuy.
ANAB's RSI Indicator ascending out of oversold territory
The RSI Indicator for ANAB moved out of oversold territory on October 14, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 21 similar instances when the indicator left oversold territory. In 18 of the 21 cases the stock moved higher. This puts the odds of a move higher at 86%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 48 of 60 cases where ANAB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.
The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on ANAB as a result. In 73 of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 78%.
The Moving Average Convergence Divergence (MACD) for ANAB just turned positive on October 15, 2026. Looking at past instances where ANAB's MACD turned positive, the stock continued to rise in 42 of 53 cases over the following month. The odds of a continued upward trend are 79%.
Following a +5.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where ANAB advanced for three days, in 223 of 283 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
ANAB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ANAB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
The Aroon Indicator for ANAB entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 35 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 38 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. ANAB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: ANAB's P/B Ratio (112.808) is very high in comparison to the industry average of (2.973). P/E Ratio (-47.157) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (6.614) is also within normal values, averaging (438.009).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Momentum Indicator for QTTB turns positive, indicating new upward trend
QTTB saw its Momentum Indicator move above the 0 level on October 20, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 93 similar instances where the indicator turned positive. In 82 of the 93 cases, the stock moved higher in the following days. The odds of a move higher are at 88%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where QTTB's RSI Indicator exited the oversold zone, 21 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 44 of 59 cases where QTTB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
The Moving Average Convergence Divergence (MACD) for QTTB just turned positive on October 08, 2026. Looking at past instances where QTTB's MACD turned positive, the stock continued to rise in 33 of 38 cases over the following month. The odds of a continued upward trend are 87%.
Following a +11.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where QTTB advanced for three days, in 212 of 245 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
QTTB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where QTTB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
The Aroon Indicator for QTTB entered a downward trend on October 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 16 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 25 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 44 (best 1 - 100 worst), indicating steady price growth. QTTB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.437) is normal, around the industry mean (2.988). P/E Ratio (2.761) is within average values for comparable stocks, (-1.158). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (123.903) among similar stocks. P/S Ratio (3.034) is also within normal values, averaging (438.009).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QTTB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
ANAB | QTTB | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 5 | 4 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 93 Overvalued | 74 Overvalued | |
PROFIT vs RISK RATING 1..100 | 38 | 100 | |
SMR RATING 1..100 | 99 | 16 | |
PRICE GROWTH RATING 1..100 | 49 | 44 | |
P/E GROWTH RATING 1..100 | 35 | 25 | |
SEASONALITY SCORE 1..100 | 65 | 90 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
QTTB's Valuation (74) in the null industry is in the same range as ANAB (93) in the Biotechnology industry. This means that QTTB’s stock grew similarly to ANAB’s over the last 12 months.
ANAB's Profit vs Risk Rating (38) in the Biotechnology industry is somewhat better than the same rating for QTTB (100) in the null industry. This means that ANAB’s stock grew somewhat faster than QTTB’s over the last 12 months.
QTTB's SMR Rating (16) in the null industry is significantly better than the same rating for ANAB (99) in the Biotechnology industry. This means that QTTB’s stock grew significantly faster than ANAB’s over the last 12 months.
QTTB's Price Growth Rating (44) in the null industry is in the same range as ANAB (49) in the Biotechnology industry. This means that QTTB’s stock grew similarly to ANAB’s over the last 12 months.
QTTB's P/E Growth Rating (25) in the null industry is in the same range as ANAB (35) in the Biotechnology industry. This means that QTTB’s stock grew similarly to ANAB’s over the last 12 months.
| ANAB | QTTB | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 86% | 2 days ago 68% |
| Stochastic ODDS (%) | 1 day ago 80% | 2 days ago 75% |
| Momentum ODDS (%) | 1 day ago 78% | 2 days ago 88% |
| MACD ODDS (%) | 1 day ago 79% | 2 days ago 87% |
| TrendWeek ODDS (%) | 1 day ago 81% | 2 days ago 86% |
| TrendMonth ODDS (%) | 1 day ago 81% | 2 days ago 88% |
| Advances ODDS (%) | 1 day ago 79% | 2 days ago 87% |
| Declines ODDS (%) | 16 days ago 81% | 7 days ago 88% |
| BollingerBands ODDS (%) | 1 day ago 77% | 2 days ago 86% |
| Aroon ODDS (%) | 1 day ago 82% | 2 days ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ANAB’s FA Score shows that 1 FA rating(s) are green while QTTB’s FA Score has 2 green FA rating(s).
- ANAB’s FA Score: 1 green, 4 red.
- QTTB’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ANAB’s TA Score shows that 6 TA indicator(s) are bullish while QTTB’s TA Score has 6 bullish TA indicator(s).
- ANAB’s TA Score: 6 bullish, 2 bearish.
- QTTB’s TA Score: 6 bullish, 2 bearish.
Price Growth
ANAB (@Biotechnology) experienced а +2.72% price change this week, while QTTB (@Biotechnology) price change was +8.24% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.
Reported Earning Dates
ANAB is expected to report earnings on Nov 03, 2026.
QTTB is expected to report earnings on Nov 12, 2026.
Industries' Descriptions
@Biotechnology (-1.10% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
ANAB and
Correlation & Price change
A.I.dvisor indicates that over the last year, ANAB has been loosely correlated with CLRB. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ANAB jumps, then CLRB could also see price increases.
| Ticker / NAME | Correlation To ANAB | 1D Price Change % | ||
|---|---|---|---|---|
| ANAB | 100% | +0.33% | ||
| CLRB - ANAB | 40% Loosely correlated | -8.59% | ||
| QTTB - ANAB | 38% Loosely correlated | +1.50% | ||
| AMRN - ANAB | 38% Loosely correlated | +0.78% | ||
| JBIO - ANAB | 36% Loosely correlated | -1.45% | ||
| ORKA - ANAB | 35% Loosely correlated | +1.54% | ||
More | ||||